Skip to main content

Moderna’s COVID-19 vaccine defends against delta variant: study

Moderna’s COVID-19 vaccine resulted in antibody activity against variants, including the highly transmissible delta variant, six months following the second dose, a study found.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.